Polysaccharides: The Potential Prebiotics for Metabolic Associated Fatty Liver Disease (MAFLD)
Nutrients · 25.08.2023 · 15 (17) · 3722
DOI: 10.3390/nu15173722 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 25.08.2023. Verfasst von Qin Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory of Digestive Diseases, Department of Gastroenterology and Hepatology, Tianjin Institute of Digestive Diseases, National Key Cl…. Hauptthemen laut MEDLINE: Prebiotics, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tianjin Health Science and Technology, Scientific research project of Tianjin Municipal Commission of Education, Tianjin Health Science and Technology Project.
Abstract (Originalsprache)
Metabolic (dysfunction) associated fatty liver disease (MAFLD) is recognized as the most prevalent chronic liver disease globally. However, its pathogenesis remains incompletely understood. Recent advancements in the gut-liver axis offer novel insights into the development of MAFLD. Polysaccharides, primarily derived from fungal and algal sources, abundantly exist in the human diet and exert beneficial effects on glycometabolism, lipid metabolism, inflammation, immune modulation, oxidative stress, and the release of MAFLD. Numerous studies have demonstrated that these bioactivities of polysaccharides are associated with their prebiotic properties, including the ability to modulate the gut microbiome profile, maintain gut barrier integrity, regulate metabolites produced by gut microbiota such as lipopolysaccharide (LPS), short-chain fatty acids (SCFAs), and bile acids (BAs), and contribute to intestinal homeostasis. This narrative review aims to present a comprehensive summary of the current understanding of the protective effects of polysaccharides on MAFLD through their interactions with the gut microbiota and its metabolites. Specifically, we highlight the potential molecular mechanisms underlying the prebiotic effects of polysaccharides, which may give new avenues for the prevention and treatment of MAFLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tianjin Key Laboratory of Digestive Diseases, Department of Gastroenterology and Hepatology, Tianjin Institute of Digestive Diseases, National Key Clinical Specialty, General Hospital, Tianjin Medical University, Tianji…
- Department of Pharmacy, General Hospital, Tianjin Medical University, Tianjin 300052, China.
ORCID-Profile: Hailong Cao
Förderung
- Tianjin Health Science and Technology
- Scientific research project of Tianjin Municipal Commission of Education
- Tianjin Health Science and Technology Project
Zitieren
APA
Guo, Q., Li, Y., Dai, X., Wang, B., Zhang, J., & Cao, H. (2023). Polysaccharides: The Potential Prebiotics for Metabolic Associated Fatty Liver Disease (MAFLD). Nutrients, 15(17), 3722. https://doi.org/10.3390/nu15173722
Vancouver
Guo Q, Li Y, Dai X, Wang B, Zhang J, Cao H. Polysaccharides: The Potential Prebiotics for Metabolic Associated Fatty Liver Disease (MAFLD). Nutrients. 2023;15(17):3722. doi:10.3390/nu15173722
BibTeX
@article{Guo2023,
author = {Guo, Qin and Li, Yun and Dai, Xin and Wang, Bangmao and Zhang, Jie and Cao, Hailong},
title = {Polysaccharides: The Potential Prebiotics for Metabolic Associated Fatty Liver Disease (MAFLD)},
journal = {Nutrients},
year = {2023},
volume = {15},
number = {17},
pages = {3722},
doi = {10.3390/nu15173722}
}
EUVIMED